Related Experiment Video

Updated: Jul 3, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Preemptive antibiotic treatment based on gram staining reduced the incidence of ARDS in mechanically ventilated

Asako Matsushima1, Osamu Tasaki, Kentaro Shimizu

  • 1Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan. matushima@hp-emerg.med.osaka-u.ac.jp

The Journal of Trauma
|July 19, 2008
PubMed
Abstract

Insights

Early diagnosis of respiratory infections using bedside gram staining significantly reduced ventilator-associated pneumonia (VAP) and acute respiratory distress syndrome (ARDS) incidence in ICU patients. This preemptive antibiotic strategy improved outcomes without increasing antibiotic use.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pulmonary Medicine

Background:

  • Ventilator-associated pneumonia (VAP) is a significant ICU complication with high mortality.
  • VAP can lead to acute respiratory distress syndrome (ARDS).
  • Current VAP treatment guidelines necessitate improved diagnostic and therapeutic strategies.

Purpose of the Study:

  • To evaluate the efficacy of preemptive antibiotic therapy guided by bedside gram staining for VAP prevention.
  • To assess the impact of this strategy on VAP and ARDS incidence and associated mortality.

Main Methods:

  • A comparative study divided patients into two periods: standard antibiotic guidelines vs. preemptive therapy based on gram staining.
  • Included were endotracheally intubated ICU patients requiring >72 hours of ventilation.
  • Excluded were patients <16 years or with brain death.

Main Results:

  • The incidence of VAP decreased from 22% to 9% (p < 0.01) in the gram staining group.
  • ARDS incidence significantly reduced from 11% to 3% (p < 0.01).
  • VAP-associated mortality dropped from 5% to 0.8% (p < 0.05) without increased antibiotic duration or quantity.

Conclusions:

  • Early diagnosis and treatment of respiratory infections via gram staining effectively reduce VAP and ARDS.
  • This approach offers significant clinical benefits without escalating antibiotic consumption.
  • Bedside gram staining provides a valuable tool for optimizing VAP management in ICUs.

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...